I nterferon-gamma (IFN ␥ ) is a 34-50-kD cytokine exclusively produced by T-cells and natural killer cells (Farrar and Schreiber 1993) , which plays a key regulatory role in specific immunity. For this reason, IFN ␥ has been widely investigated in immunological re-search. In addition to in vitro studies, many investigators also attempted to demonstrate IFN␥ protein immunohistochemically in healthy and diseased tissues. For example, studies have been undertaken to localize IFN␥ in rheumatoid arthritis (Ulfgren et al. 1995; Smeets et al. 1998a,b) , atherosclerosis (Hansson et al. 1989; Frostegard et al. 1999) , and inflammatory bowel disease (Camoglio et al. 1998) . Cytokine immunohistochemistry is frequently used in combination with molecular biological techniques such as in situ hybridization (ISH) and polymerase chain reaction (RT-PCR) to gain insight into the biological role of cytokines in diseased tissues. However, our own immunohis-tochemical experiences with several anti-IFN ␥ antibodies have raised doubts concerning the specificity and the consistency of the staining results obtained. This provides the background for the present study, in which we verified the specificity of anti-IFN ␥ immunohistochemical staining using a panel of commercially available poly-and monoclonal antibodies.
Materials and Methods

Human Tissue Samples
Tonsils with hyperplastic reactive changes ( n ϭ 3, age 3-6 years), inflammatory abdominal aortic aneurysms (IAAA) ( n ϭ 2, age 60 and 75 years), and synovial tissue specimens from knee joint with rheumatoid arthritis (RA synovium) ( n ϭ 3, age 62-77 years) were obtained at surgery. These tissue samples were used as positive controls for IFN ␥ staining, based on the expression of IFN ␥ mRNA as detected with RT-PCR (Ramshaw et al. 1994; Harabuchi et al. 1996; Kotake et al. 1997) . Moreover, IFN ␥ protein was detected with immunohistochemistry in tonsil and RA synovium (Hoefakker et al. 1993; Dolhain et al. 1996; Smeets et al. 1998a,b) and ELISA in IAAA (Szekanecz et al. 1994) . Non-atherosclerotic vessel segments ( n ϭ 4, age 10-14 years) were used as controls. All tissue samples were snapfrozen in liquid nitrogen and stored at Ϫ 80C. Six-m cryostat serial sections were cut, and stored at Ϫ 80C.
Cell Specimens
Cultured T-cell lines from human aortic atherosclerotic plaques were prepared as previously described (De Boer et al. 1999) . Cells were cultured (5 ϫ 10 6 /ml) in Iscoves modification of Dulbecco's medium (IMDM; Gibco BRL Life Technologies, Paisley, Scotland) supplemented with 10% pooled human serum in the presence or absence of 10 ng/ml phorbol-12-myristate-13-acetate (PMA) (Sigma; St Louis, MO) and 100 ng ionomycin (Calbiochem; La Jolla, CA) in 25-cm 2 culture flasks. Monensin (Sigma) was added (2.88 M/ml in dimethylsulfoxide) to prevent active cytokine excretion, thus resulting in intracellular accumulation of IFN ␥ . After 4 h, the cell suspensions were washed three times with PBS without protein additives and divided into three fractions. The first fraction was adhered overnight at 4C on Bio-Rad adhesion slides (Hercules, CA), 2 ϫ 10 4 cells per spot. After brief washing with PBS, these cell specimens were stored in PBS at 4C and used for immunocytochemistry within 2 days. The second fraction was concentrated in an Eppendorf tube in 100 l PBS (2 ϫ 10 5 cells), mixed gently with 100 l Tissue-Tek OCT compound (Sakura; Zoeterwoude, The Netherlands), and snap-frozen in liquid nitrogen. Six-m cryostat sections were cut and handled as described for tissue cryostat sections. The remaining cells were used for FACS analysis.
Immunostaining Reagents
We employed 13 anti-human anti-IFN ␥ poly-and monoclonal antibodies, as listed in Table 1 . As indicated in Table 1 , seven anti-IFN ␥ antibodies were advertised and/or regularly applied for immunocytochemistry/-histochemistry. Other primary antibodies used in this study are listed in Table 2 .
Biotinylated goat anti-mouse Ig (GAM/bio), biotinylated goat anti-rabbit Ig (GAR/bio), alkaline phosphatase-conjugated goat anti-rabbit Ig (GAR/AP), normal mouse serum (NMS), normal goat serum (NGS), normal swine serum (NSS), AP-conjugated streptavidin (streptavidin/AP), streptavidin-biotin complex with HRP (SABC/HRP), rabbit antifluorescein (rabbit anti-FITC), and endogenous biotin block- 
Immunocytochemistry and Immunohistochemistry
Cell specimens and cryostat tissue sections were fixed in either acetone (10 min, 4C) or 4% paraformaldehyde (PFA) in PBS (5 min, room temperature). When PFA fixation was used, 0.1% saponin was added for membrane permeabilization (Sander et al. 1991; Dolhain et al. 1993 ) to all incubation steps. Endogenous peroxidase activity was blocked with 0.1% sodium azide ϩ 0.3% peroxide in 50 mM Tris-HClbuffered saline, pH 7.8 (TBS) (20 min, RT) (Li et al. 1987) . Endogenous biotin was blocked with subsequent incubations of 0.1% avidin and 0.01% d -biotin from the DAKO endogenous biotin blocking kit (twice for 15 min at RT). Primary antibodies and antibody-enzyme conjugates were diluted in TBS ϩ 1% bovine serum albumin (BSA). Single immunostaining consisted of overnight incubation at 4C with the selected primary anti-IFN ␥ antibodies (Table 1) and standard SABC/HRP detection. HRP activity was visualized with AEC (0.5 mg/ml) and peroxide (0.01%) in acetate buffer (pH 5.2, 50 mM). Controls consisted of replacing the primary antibody with a non-immune mouse antibody of identical subclass (DAKO). Specific IgG concentration and Ig isotype/subclass were matched with the specific primary antibody from the original single-staining experiment.
Immunoenzyme Multiple Staining of Tissue Sections
A double-staining procedure based on a multistep technique (van der Loos 1999) was applied for comparison of IFN ␥ immunostaining with different cellular markers. The stain-ing procedure consisted of the following subsequent incubation steps: NGS (1:10, 15 min), IFN ␥ antibody (clones MMHG-1 1:100, MD-2 1:50 or rabbit antibody Genzyme IP-500 1:5000, all overnight at 4C), GAM/bio (1:200, 30 min) or GAR/bio (1:400, 30 min), SABC/HRP (1:100, 30 min), and NMS (1:10, 15 min). For the goat anti-IFN ␥ antibody, the first part of the double staining consisted of NSS (1:10, 15 min), IFN ␥ goat antibody (1:100, overnight at 4C), SAG/biotin (1:100, 30 min), SABC/HRP (1:100, 30 min), and NGS (1:10, 15 min). Then, a panel of directly conjugated primary antibodies was applied: FITC-conjugated anti-CD3, CD2, CD138, biotinylated anti-CD68 (van der Loos and Göbel 2000), and PE-conjugated CD56 (60 min) ( Table 2) . For the FITC-and PE-conjugated antibodies, further steps were as follows: rabbit anti-FITC (1:1000, 15 min), or rabbit anti-PE (1:200, 15 min) and PowerVision-GAR/AP (undiluted, 30 min). The biotinylated antibody was followed by streptavidin/AP (1:100, 30 min). The enzymatic activities of AP and HRP were visualized in blue (Fast Blue BB) and red (AEC), respectively (van der Loos 1999).
Two triple immunoenzyme stainings using ␤ -galactosidase (turquoise), AP (red), and HRP (brown) as marker enzymes, and blue nuclear counterstain (van der Loos 1999), were performed to monitor the major cell types present in the tissue specimens. The first consisted of anti-␣ -actin (mouse IgG 2a ) and anti-CD68 (mouse IgG 1 ), combined with FITC-conjugated anti-CD3, in a multistep staining procedure. Anti-␣ -actin and anti-CD68 were incubated in a cocktail, followed by GAM-IgG 2a /biotin (1:50), GAM-IgG 1 /HRP (1:50) in a cocktail (30 min) and streptavidin/GAL (1:40, 30 min). After a blocking step with normal mouse serum (1:10, 15 min), incubation was performed with FITC-conjugated anti-CD3, rabbit anti-FITC (1:1000, 15 min), and GAR/AP (1:20, 30 min). Smooth muscle cells, macrophages, and T-cells were immunostained in turquoise, brown, and red, respectively. The second consisted of anti-␣ -actin (mouse IgG 2a ), anti-CD68 (mouse IgG 1 ), and anti-von Willebrand factor (rabbit) in one cocktail, followed by GAM-IgG 2a /bio (1:50), GAM-IgG 1 /HRP (1:50), GAR/AP (1:20) in cocktail (30 min), and streptavidin/GAL (1:40, 30 min). Smooth muscle cells, macrophages, and endothelial cells were immunostained in turquoise, brown, and red, respectively.
FACS Analysis
All 13 anti-IFN ␥ antibodies were applied for indirect intracellular FACS staining. In vitro PMA/ionomycin-stimulated T-cells were fixed with 1% PFA in PBS (10 min, 4C) and treated with 0.1% saponin for permeabilization (Sander et al. 1991) . Final concentrations of the primary antibodies diluted in PBS with 0.1% saponin and 1% BSA (60 min, 4C) were similar as mentioned for immunohistochemistry/cytochemistry in Table 1 . Depending on the primary antibody, PE-conjugated GAM, GAR, or SAG (all 1:200) was used as second-step reagent (30 min, 4C). Fluorescence of 10 4 cells was analyzed on a FACS Calibur (Becton Dickinson, Richmond, CA).
Leakage of IFN␥ from Tissue Sections
From the frozen stimulated and unstimulated cultured T-cells, 20 6-m sections were cut and mounted on organosilanecoated slides. Either unfixed, acetone-fixed (10 min, 4C, airdried) or PFA-fixed (5 min, RT, briefly washed three times with TBS) sections were encircled with a wax pen and covered with 100 l TBS for 30 min. Fifty-l samples were taken from the buffer covering the tissue sections and subjected to IFN␥ ELISA. A Pelikine IFN␥ kit was used, following the instructions as supplied by the manufacturer (CLB; Amsterdam, The Netherlands).
Results
IFN␥ Staining Characteristics with Cultured T-cells
Stimulated intact T-cells on adhesion slides showed a distinct signal in the majority of the cells with 12 of 13 anti-IFN␥ antibodies ( Figure 3E ). Unstimulated cells were negative or occasionally weakly positive ( Figure  3B ). Stimulated T-cells showed a much stronger stain-ing intensity after PFA fixation ( Figure 3E ) than after acetone fixation ( Figure 3D ). These immunocytochemical staining results were completely confirmed by FACS analysis (Table 3 ). An interesting observation was that IFN␥ immunohistochemistry was consistently negative after cryosectioning of stimulated T-cells, (Table 3 ; Figure 3F ), even after raising the primary antibody concentration to 50 g/ml. This result was found after both acetone and PFA fixation.
To test the possible leakage of IFN␥ from either unfixed, acetone-, or PFA-fixed cultured T-cell sections, buffer covering the specimens was subjected to ELISA. Buffers covering unfixed sections from stimulated T-cells contained IFN␥ protein at 14.4-49.3 pg/ml (nϭ4) and concentrations below detection limit (Ϯ 10 pg/ml) for the unstimulated cells. After acetone or PFA fixation, only values close to or below detection limit were found. Performance of this leakage test with the other tissue specimens failed because IFN␥ values with unfixed sections were too low.
IFN␥ Staining Characteristics with Tissue Sections
Comparison of the IFN␥ single staining with triple immunostainings marking the major cellular components in tonsil, RA synovium, and IAAA indicated positive IFN␥ staining of various tissue components with a preference for smooth muscle cells (nϭ8), endothelial cells (nϭ4), extracellular matrix (nϭ4), macrophages (nϭ1), and nerve bundles (nϭ2). Consider- ing only those IFN␥ antibodies that were advertised and/or regularly applied for immunohistochemistry (nϭ7 ; Table 1 ), there was no consistent staining pattern either. The positive cell types included smooth muscle cells (nϭ4), endothelial cells (nϭ3), extracellular matrix (nϭ2), macrophages (nϭ1), and nerve bundles (nϭ1). Moreover, distinct expression of IFN␥ with T-cells was not observed. Remarkably, a strong IFN␥ smooth muscle cell positivity was also found in the media of non-atherosclerotic and non-inflamed aortic segments ( Figure 1K ). Apart from these various cellular constituents a distinct, consistently positive cell population was observed with 12 out of 13 antibodies. This characteristic cell population was found exclusively positive without additional staining of other cellular elements with three anti-IFN␥ antibodies: clones MMHG-1, 35B10G6, and RD Systems goat antibody (Table 3) . These positive cells were found in relatively low amounts in tonsil and IAAA but were abundant in the RA synovium ( Figures 2B-2D ). Negative control experiments did not show any staining ( Figures 1I and 2A) . Typical results of anti-IFN␥ immunohistochemistry of all three tissues are summarized in Table 3 and illustrated in Figures 1A-1H and Figures 2B-2D .
Comparison of acetone and PFA as fixatives before IFN␥ immunostaining showed similar results with respect to localization and staining intensity. Raising the antibody concentration (clones MMHG-1, MD-2, Genzyme rabbit antibody, and RD Systems goat antibody) up to 50 g/ml, revealed over-stained images with intensely positive cells as described above.
To investigate the possible binding of IFN␥ to its concomitant receptor, tissue localization of IFN␥ immunostaining was compared with IFN␥ receptor staining in serial sections. In RA synovium, IAAA, and tonsil, the anti-IFN␥ receptor antibody showed distinct positive staining of endothelial cells, macrophages, and weak staining of smooth muscle cells ( Figure 1J) , which could only partly be co-localized with the anti-IFN␥ staining (Figures 1B-1H ). Moreover, medial smooth muscle cells in non-atherosclerotic aortas were IFN␥ receptor ( Figure 1L ) -negative, which contrasted with the strong IFN␥ positivity ( Figure 1K ).
Cellular Specificity of Anti-IFN␥ Antibodies
To reveal the characteristic cell type showing positive staining with almost all anti-IFN␥ antibodies, clones MMHG-1, MD-2, Genzyme rabbit antibody, and RD Systems goat antibody were subjected to immunoenzyme double-staining experiments with cellular markers on the RA synovium and tonsil cryostat sections. It appeared that T-cells (CD2, CD3), natural killer cells (CD56), and macrophages (CD68) did not co-localize with the IFN␥-positive cell population (Table 3) .
However, a subpopulation of approximately 5% of all CD138 positive plasma cells co-localized with IFN␥positive cells, observed as a purple mixed-color in the cytoplasm (Figures 4A-4D) .
Discussion
In the present study we have compared the immunohistochemical applicability of 13 different anti-IFN␥ antibodies on cryostat tissue sections. IFN␥ immunohistochemical single-and double-staining analysis of the tissue sections showed a large variation in staining patterns, but positive staining of T-lymphocytes was never observed. In this context, it should be emphasized that not all 13 IFN␥-antibodies used in this study were originally developed and tested for an immunohistochemical application. This also could explain the highly variable immunohistochemical staining patterns ( Figures 1A-1H ), despite the fact that the antibodies were capable of detecting IFN␥ in cultured and in vitro-stimulated intact T-cells (Table 3) . For example, anti-IFN␥ clone MD-2 was first described for ELISA application by Van der Meide et al. (1985) and only much later was applied for immunohistochemical purposes (Hoefakker et al. 1993 ). The latter application is subsequently cited by other investigators and has led to the use of this antibody on tissue sections (Dolhain et al. 1996; Thepen et al. 1996; Van Hoffen et al. 1996; Smeets et al. 1998b) .
We also verified the immunoreactivity of the anti-IFN␥ antibodies on intact PMA/ionomycin-stimulated T-cells, known to contain substantial amounts of IFN␥. Intact in vitro-stimulated T-cells showed a typical intracellular IFN␥ staining pattern ( Figure 3E ) similar to the findings by others (Sander et al. 1991; Dolhain et al. 1993; Krouwels et al. 1997 ). In addition, 12 of 13 anti-IFN␥ antibodies subjected to FACS analysis showed positive staining with in vitro-stimulated T-cells, whereas unstimulated cells were negative. These experiments reveal that 12 of 13 anti-IFN␥ antibodies have the potential to recognize IFN␥ in in vitro-stimulated intact T-cells. In contrast to these intact in vitro-stimulated T-cells, IFN␥ immunohistochemistry performed on cryosections prepared from these cells gave negative results ( Figure 3F) . Given the fact that these in vitro PMA/ ionomycin-stimulated T-cells contain higher levels of IFN␥ protein than activated T-cells in vivo (Del Prete et al. 1991) , it may be not surprising that IFN␥ immunostaining of T-cells in tissue sections of IAAA, RA synovium, and tonsil was negative.
The present experiments show that there is a clear discrepancy between the results obtained with cultured intact T-cells and those with cryosectioned T-cells. Apparently, immunocytochemical staining of intact T-cells is not a reliable model system for testing the immunohistochemical applicability of IFN␥ antibodies on cryostat tissue sections, as has been suggested in the literature Dolhain et al. 1996) .
It is remarkable that in the majority of papers the observed IFN␥ positivity simply was assumed to represent T-cells. Confirmation by double staining was performed only by Dolhain et al. (1996) , who showed CD3/IFN␥ co-localization in RA synovium samples. In this study we could not reproduce those results, even in the same type of tissue. Attempting to demonstrate the co-localization of IFN␥ in T-cells, we performed double staining with both CD2 and CD3. Double staining with CD2 was also performed because CD2 is not downregulated after T-cell activation (Moingeon et al. 1991) , in contrast to CD3 (Van Lier et al. 1987 ). Furthermore, we have been able to detect IFN␥/CD3 co-localization in in vitro-stimulated T-cells (not shown). We have no explanation for the different results in our study compared to that of Dolhain et al. (1996) .
The obvious difference between in vitro-stimulated intact T-cells and cryostat tissue sections prepared from these cells is the presence of an outer membrane. Therefore, it appears attractive to hypothesize that intact T-cells retain IFN␥ more effectively during the fixation procedure, either with acetone or PFA, than a sectioned cell. Possibly IFN␥ protein is lost from the cryosectioned T-cells during the fixation procedure due to extraction of the antigen (Larsson 1993) or due to poor fixation. Arguments in favor of this leakagehypothesis are the observations that (a) IFN␥ is detectable by ELISA in the buffer covering the unfixed in vitro-stimulated T-cell cryostat sections. However, after fixation of the T-cell cryostat sections with either acetone or PFA, almost no IFN␥ is detectable in the overlying buffer, whereas the immunohistochemical visualization of IFN␥ in cryosectioned stimulated T-cells was completely negative also ( Figure 3F ). (b) Acetone fixation of intact T-cells, which completely dissolves the fatty membrane structures, shows a near-negative IFN␥ staining result ( Figure 3D ), whereas the same cells were intensely positive after PFA fixation ( Figure 3E ). IFN␥ immunohistochemistry on cryostat tissue sections from tonsil, RA synovium, and IAAA revealed highly variable staining patterns with different antibodies. A variety of cellular constituents were positive, with a high preference for smooth muscle cells. Apart from staining of various cellular constituents, 12 of 13 anti-IFN␥ antibodies revealed staining of a CD138positive plasma cell subset (Figure 4) but not of T-cells. Non-T-cell positivity with anti-IFN␥ antibodies has been reported previously and is considered a result of receptor-bound IFN␥ (Dolhain et al. 1996) . Indeed, some of the IFN␥ staining patterns resemble the IFN␥ receptor staining pattern ( Figure 1J ). However, there are indirect arguments that certainly not all non-T-cell IFN␥ positivity can be explained as receptor bound. (a) In the non-atherosclerotic aortas, without any morphological signs of inflammation, the medial smooth muscle cells showed massive IFN␥ positivity, whereas the IFN␥ receptor was negative ( Figures 1L and 1K ). (b) When non-T-cell IFN␥ staining in non-atherosclerotic aortas was caused indeed by receptor-bound IFN␥, this would have induced major histocompatibility complex Class II expression (HLA-DR, DP, DQ). However, this was not observed. This absence of HLA-DR, DP, and DQ positivity in non-atherosclerotic aortas also excludes the possibility that IFN␥ receptor staining is perhaps missed because IFN␥ blocks the antibody binding site.
Considering the IFN␥ positivity of plasma cells, some investigators claimed expression of trace amounts of IFN␥ by B-lymphocytes under in vitro conditions (Pang et al. 1992; Jelinek and Braaten 1995) . In our opinion, these findings cannot be matched with the abundant and strong IFN␥ staining of the plasma cell subpopulation as observed in all three tissues studied. Therefore, apart from the non-T-cell staining of various cellular constituents, also the plasma cell IFN␥positivity was considered as a staining artifact. This artifactual staining might be caused by the formation of conditional epitopes (Willingham 1999) or redistribution of small molecular weight antigens (Larsson 1993) , both of which may occur during the fixation procedure.
The nonspecific positive staining of the plasma cell subpopulation was shown not to be unique for anti-IFN␥ antibodies. Using, for example, anti-IL-2 or anti-IL-4 antibodies, known to be secreted by T-cells upon activation, we also observed a strong positivity in RA synovium of the same plasma cell population that was found positive with anti-IFN␥ antibodies, whereas positive T-cells were not observed. Non-T-cell IFN␥ staining may be the basis for conflicting immunohistochemical staining results when different anti-IFN␥ antibodies were applied to similar tissue specimens. For example, reported in chronic recurrent tonsillitis a few IFN␥ positive cells using clone DIK-1, whereas Hoefakker et al. (1993) reported massive IFN␥ positivity with clone MD-2 in the same tissue. Moreover, the application of extremely high concentrations of IFN␥ antibody (MD-2, 45-100 g/ml) (Thepen et al. 1996; Van Hoffen et al. 1996) for immunostaining of cryostat sections may introduce staining artifacts. Not only may the IFN␥ antibodies themselves may play a role but also the application of different tissue fixatives before the IFN␥ staining procedure may have an effect on the final staining result. For example, acetone fixation was employed by Hoefakker et al. (1993) , Dolhain et al. (1996) , Smeets et al. (1998b) , and Thepen et al. (1996), whereas PFA fixation and saponin treatment were used by Ulfgren et al. (1995) , Smeets et al. (1998a) , and . In our hands, a comparison of these two popular fixatives showed a dramatic loss of IFN␥ staining after acetone fixation of intact T-cells ( Figures 3D and 3E) , confirming the use of PFA fixation as indicated by . However, in considering the non-T-cell IFN␥ staining of tissue sections after either acetone or PFA fixation, there was no difference regarding localization and intensity. This observation is another indication that the non-T-cell staining in tissue sections after acetone fixation has a nonspecific basis. The present description of nonspecific IFN␥ immunohistochemical staining shows analogy with the false-positive staining of anti-RAP-5 antibody detecting the ras oncogene product p21 as reported by Samowitz et al. (1988) and Gutheil et al. (1989) . Although these investigators employed immunoprecipitation and Western blotting as contra-evidence, they finally proved that the initial RAP-5 immunohistochemical positivity could be recognized as completely nonspecific. Furthermore, Kaino et al. (2000) described the crossreactivity of anti-rat CD45RA antibody with glucagon-producing islet ␣-cells in formalin-fixed and paraffin-embedded rat pancreatic tissue.
We consider further testing of the anti-IFN␥ antibody specificity using absorption with IFN␥ antigen not to be useful. In our opinion and that of others (Burry 2000) , an absorption control does not prove the specificity of an antibody for its antigen in a fixed tissue section. For example, anti-IFN␥ clone MD-2 was subjected successfully to such an absorption experiment (Hoefakker et al. 1993 ), but our present data clearly show this antibody as not to be specific for tissue IFN␥ staining (Table 3 ; Figure 1L ).
Future Perspectives for IFN␥ Immunostaining?
At the request of one of the reviewers and after discussions at the latest Congress of Histochemistry and Cytochemistry, we tested the option of prefixation by perfusion or immersion in PFA before freezing. This method has been applied, for example, by Van Noorden and Polak (1985) , Van Noorden (1986) , and Larsson (1988) , and is especially recommended for detection of small peptides and hormones. However, among the vast majority of reports applying acetone or PFA postfixation of cryosections, we could find only one report using prefixation for the detection of IFN␥ (Kakazu et al. 1999) . Our pilot experiment showed that PFA prefixation of in vitro-stimulated T-cells indeed retains and preserves IFN␥ after freezing and sectioning (Figures 5A and 5B) , in contrast to PFA postfixation ( Figure  3F ). Apparently, PFA postfixation of a cryosection is too slow (Fox et al. 1985) and cannot prevent leaking of IFN␥ from cryosections. However, PFA prefixation of a closed cell allows a firm fixation of IFN␥, thus preventing leakage even from tissue sections. Thus far, however, we have not been able to demonstrate IFN␥ immunohistochemically in a few PFA-prefixed and 20% sucrose freeze-protected tissue blocks tested. Nevertheless, it could be that PFA prefixation is the key to successful immunohistochemical visualization of IFN␥ and perhaps of other cytokines. Moreover, we suspect that missing the IFN␥ staining of activated T-cells in cryosections from PFA prefixed tissue blocks, in contrast to prefixed in vitro-stimulated T-cells, may be a sensitivity problem of current detection systems even when tyramide amplification is used.
Conclusion
Using the present panel of anti-IFN␥ antibodies, specific staining of activated T-cells (Th-1 type) in tissue sections is not observed with generally applied staining procedures, a phenomenon most likely due to either the lack of sensitivity and/or to leakage of IFN␥ from the sections. On the basis of the present findings, we conclude that IFN␥ immunostaining of cryostat tissue sections may result in significant staining artifacts. As a consequence, IFN␥ immunostaining results on cryostat tissue sections should be interpreted with great caution. The performance of double staining is highly recommended, at least for the distinction between "true" IFN␥ positivity and nonspecific staining. 
